Episcleral brachytherapy for retinoblastoma.

Jose J EchegarayYahya A Al-ZahraniArun D Singh

Published in: The British journal of ophthalmology (2019)

EB is an effective primary or secondary treatment modality for selected retinoblastoma eyes (groups B and C). Advanced group D tumours may represent a risk factor for local recurrence. Visually significant complications such as radiation retinopathy should be anticipated.

Keyphrases

high dose
radiation therapy
risk factors
squamous cell carcinoma
low dose
radiation induced